Drugs and Prison - Statistics from the last yearAndrew Brown
The Ministry of Justice have recently reported that more drugs are being found in prisons in England. These slides are a compilation of the data that we've seen on drugs and prison over the last year.
Interesting things you might have missed - April 15Andrew Brown
This document contains information on various topics related to alcohol and other drugs in the UK, including:
- The increasing number of new psychoactive substances identified by authorities.
- Reduced funding for alcohol services in areas with high alcohol harms.
- Decreased participation in teacher training on drug education after government funding was withdrawn.
- Rising numbers of hospital admissions for cannabis-induced psychosis in young people.
- Increasing sanctions for unemployment benefits recipients with drug and alcohol problems.
- Hospital admissions for drug poisonings, highest for opiates in males.
- Stable conviction rates in England and Wales for alcohol and drug offenses in recent years.
Interesting things about alcohol and other drugs that you might have missed -...Andrew Brown
This month includes data on:
Deaths amongst opioid users (esp those which are not overdose related); children in need and care and substance use problems; multiple and complex needs; trends in police recorded drug offences; gang membership, dependency and mental health problems; Seizures of synthetic cannabinoids in prison; public perceptions of the safety of drug taking
10 interesting things about alcohol and other drugs you may have missed in th...Andrew Brown
We scour the data on alcohol and other drugs and here are 10 things we found in the last month that might interest you, including:
The number of high risk drug users, police estimates of the cost and purity of drugs, trends in property crime, numbers in treatment in Wales, benefit claimants with drug problems in Scotland (and alcohol problems across the UK), drugs in prison, and the support needs of single homeless people
This document summarizes drug use trends and state-level actions to address drug issues in Kentucky. It finds that Kentucky has high rates of illicit drug use and drug overdose deaths compared to national averages. The most commonly cited drug in treatment is opiates, and meth lab seizures in Kentucky increased substantially from 2007 to 2009. The document discusses state-level efforts to address these issues, including prescription drug monitoring programs, drug take-back programs, and considering a per se standard for drugged driving.
Magellan Strategies conducted surveys in 8 battleground states to measure voter opinion on the EPA's newly proposed carbon emission regulations. The key findings show that on average, 37.3% of voters support the regulation, 47.1% oppose it, and 15.6% have no opinion. Additionally, 55.2% of respondents are more likely to oppose Senate candidates that support the regulation. When given further information on economic impacts, opposition increases to over 59%. The surveys conclude that any candidate supporting the regulation will face risks in these 2014 elections.
Drugs and Prison - Statistics from the last yearAndrew Brown
The Ministry of Justice have recently reported that more drugs are being found in prisons in England. These slides are a compilation of the data that we've seen on drugs and prison over the last year.
Interesting things you might have missed - April 15Andrew Brown
This document contains information on various topics related to alcohol and other drugs in the UK, including:
- The increasing number of new psychoactive substances identified by authorities.
- Reduced funding for alcohol services in areas with high alcohol harms.
- Decreased participation in teacher training on drug education after government funding was withdrawn.
- Rising numbers of hospital admissions for cannabis-induced psychosis in young people.
- Increasing sanctions for unemployment benefits recipients with drug and alcohol problems.
- Hospital admissions for drug poisonings, highest for opiates in males.
- Stable conviction rates in England and Wales for alcohol and drug offenses in recent years.
Interesting things about alcohol and other drugs that you might have missed -...Andrew Brown
This month includes data on:
Deaths amongst opioid users (esp those which are not overdose related); children in need and care and substance use problems; multiple and complex needs; trends in police recorded drug offences; gang membership, dependency and mental health problems; Seizures of synthetic cannabinoids in prison; public perceptions of the safety of drug taking
10 interesting things about alcohol and other drugs you may have missed in th...Andrew Brown
We scour the data on alcohol and other drugs and here are 10 things we found in the last month that might interest you, including:
The number of high risk drug users, police estimates of the cost and purity of drugs, trends in property crime, numbers in treatment in Wales, benefit claimants with drug problems in Scotland (and alcohol problems across the UK), drugs in prison, and the support needs of single homeless people
This document summarizes drug use trends and state-level actions to address drug issues in Kentucky. It finds that Kentucky has high rates of illicit drug use and drug overdose deaths compared to national averages. The most commonly cited drug in treatment is opiates, and meth lab seizures in Kentucky increased substantially from 2007 to 2009. The document discusses state-level efforts to address these issues, including prescription drug monitoring programs, drug take-back programs, and considering a per se standard for drugged driving.
Magellan Strategies conducted surveys in 8 battleground states to measure voter opinion on the EPA's newly proposed carbon emission regulations. The key findings show that on average, 37.3% of voters support the regulation, 47.1% oppose it, and 15.6% have no opinion. Additionally, 55.2% of respondents are more likely to oppose Senate candidates that support the regulation. When given further information on economic impacts, opposition increases to over 59%. The surveys conclude that any candidate supporting the regulation will face risks in these 2014 elections.
10 interesting things about alcohol and other drugs that you might have misse...Andrew Brown
Including... commissioners plans to reduce spending on services, injecting drug users and HIV, smoking prevalence, proportion of new Europol cases relating to drugs, time people spend on OST, regional variation on emergency hospital admissions for alcohol related liver disease, prisoners use of substances and their relationship to the crimes committed, numbers accessing domestic violence refuges, single homeless people's use of drugs and alcohol
This document provides an overview of state prescription drug monitoring programs (PMPs) and summarizes their status and operations. It finds that 44 states currently operate PMPs that collect prescription data, with most programs housed in health departments or related agencies. States fund PMPs through various means like grants, state appropriations, and licensing/registration fees. Fourteen states receive funding from licensing and registration fees specifically. The overview examines PMP laws and operations to assist policymakers in addressing prescription drug abuse, addiction, and diversion.
This document contains multiple figures and charts related to alcohol and drug use in the UK. It shows that:
1) Between 2013-2014, 584 online drug shops were identified across multiple European countries, with 18% (106 shops) no longer active by May 2014.
2) Data from 26 UK police forces showed that 10% of sexual offenses were alcohol-related.
3) A study found reductions in criminal offending after treatment for alcohol use disorder, with less offending associated with completing treatment and pharmacological therapy.
4) The document presents statistics on drug prices, purity, seizures and other measures related to alcohol and drug use in the UK.
Interesting things about alcohol and other drugs - April 2016Andrew Brown
Scotland's National Naloxone Programme was associated with a 36% reduction in opioid-related deaths after prison release and a 22% reduction after hospital discharge between 2006-2010 and 2011-2013. The number of rough sleepers in England increased 30% from 2014 to 2015, totaling 3,569. In drug-related deaths in Scotland between 2009-2014, 60% of individuals had a known psychiatric condition in the prior 6 months, most commonly depression or anxiety.
Politico Pro Health Care Briefing: Drug Safety and the Trump FDACVS Health
Opening remarks by Thomas M. Moriarty, Executive Vice President, Chief Strategy Officer and General Counsel at the Politico Pro Health Care Briefing: Drug Safety and the Trump FDA, April 5, 2017.
For more on CVS Health's work to ensure access to affordable drugs, visit: http://cvshealth.com/thought-leadership/drug-costs-efficiency-and-the-future-of-the-fda
Florida faces challenges with drug use and consequences, including drug-induced deaths higher than the national average. Marijuana and prescription opioids are primary drugs of abuse treated in Florida. Meth lab seizures rose 148% from 2007-2009. Florida is working to address these issues through initiatives like an authorized but not yet operational prescription drug monitoring program and supporting coalitions through Drug Free Communities grants. In 2010, Florida received over $338 million in federal grants to support reducing drug use.
This report examines CMS's oversight of Medicare Part D beneficiaries who receive opioid prescriptions and providers who prescribe opioids to these beneficiaries. It finds that while CMS provides guidance to Part D plan sponsors on monitoring beneficiaries at high risk of opioid overuse, it lacks complete data on the full population of beneficiaries at risk. It also finds that CMS oversees prescribing through its contractor NBI MEDIC but does not specifically analyze opioid prescription data or require reporting on actions taken regarding inappropriate opioid prescribing. The report concludes that CMS needs more comprehensive oversight to reduce the risks of opioid misuse, overdose, and inappropriate prescribing among Medicare beneficiaries.
The Impact of the AMP Final Rule: Legal, Operational, and Financial Considera...Epstein Becker Green
Part 1 of a webinar series that examines the average manufacturer price (“AMP”) Final Rule and its effect on drug pricing and contracting. Hosted by Epstein Becker Green and EBG Advisors.
The long-awaited issuance of the Final Rule addressing AMP under the Medicaid Drug Rebate Program has provided clarity in some respects but left other issues open to interpretation. In the wake of the Final Rule, other regulatory developments are already showing signs of further impacting many of the same issues.
Using the AMP Final Rule as a baseline, we will address the evolution of some of the most significant issues affecting drug pricing and contracting. We hope you can attend one or both of the sessions in this two-part series.
In this session, Constance A. Wilkinson, Member of the Firm at Epstein Becker Green, will address how the AMP final rule can impact your business. This discussion will examine various legal, operational, and financial factors, including the impact on fee-for-service arrangements with customers, value-based pricing, and reimbursement.
http://www.ebglaw.com/events/the-effect-of-the-average-manufacturer-price-final-rule-on-drug-pricing-and-contracting-part-1-the-impact-of-the-amp-final-rule-legal-operational-and-financial-considerations/
These materials have been provided for informational purposes only and are not intended and should not be construed to constitute legal advice. The content of these materials is copyrighted to Epstein Becker & Green, P.C. ATTORNEY ADVERTISING.
Vermont has many data sources on opioid misuse, abuse and dependence. This data brief covers population prevalence, substance abuse treatment, emergency department visits, and drug-related fatalities involving opioids. There are two main types of opioids that can be misused or abused: prescription opioids (e.g. oxycodone or hydrocodone) and heroin.
A recent report from the Substance Abuse and Mental Health Services Administration found that almost 80% of new heroin users in a given year previously misused prescription pain relievers. The general pattern for Vermont mirrors a national trend: a slow decrease in prescription drug misuse, expanded access to treatment for those dependent on opioids, and an increase in disease and death associated
with heroin use.
Opportunities and Barriers in Pharmaceutical Pricing: Average Manufacturer Pr...Epstein Becker Green
Part 2 of a webinar series that examines the average manufacturer price (“AMP”) Final Rule and its effect on drug pricing and contracting. Hosted by an Epstein Becker Green and EBG Advisors.
The long-awaited issuance of the Final Rule addressing AMP under the Medicaid Drug Rebate Program has provided clarity in some respects but left other issues open to interpretation. In the wake of the Final Rule, other regulatory developments are already showing signs of further impacting many of the same issues.
Using the AMP Final Rule as a baseline, we will address the evolution of some of the most significant issues affecting drug pricing and contracting. We hope you can attend one or both of the sessions in this two-part series.
In this session, Dr. Samuel R. Nussbaum, M.D., Strategic Consultant at EBG Advisors, and Lesley R. Yeung, Associate at Epstein Becker Green, will examine the pay-for-value and alternative approaches to pharmaceutical pricing. The speakers will discuss opportunities and barriers as well as highlight real-world examples.
http://www.ebglaw.com/events/the-effect-of-the-average-manufacturer-price-final-rule-on-drug-pricing-and-contracting-part-2-opportunities-and-barriers-in-pharmaceutical-pricing/
These materials have been provided for informational purposes only and are not intended and should not be construed to constitute legal advice. The content of these materials is copyrighted to Epstein Becker & Green, P.C. ATTORNEY ADVERTISING.
This document analyzes the relationship between substance abuse rates and various economic indicators in the United States from 1992-2012. Regression models were created relating substance abuse treatment data to real GDP, unemployment, and personal income. The results showed that alcohol, crack/cocaine, marijuana, heroin, and amphetamine usage were positively correlated with real GDP, while alcohol was positively correlated with unemployment. Marijuana in particular showed a strong positive relationship with real GDP and personal income. The analysis suggests substance abuse impacts economic indicators in complex ways that vary based on the specific substance.
The economic burden of prescription opioid overdose... 2013.Paul Coelho, MD
The document summarizes a study that estimates the total economic burden of prescription opioid overdose, abuse, and dependence in the United States in 2013 was $78.5 billion. Over one third of this cost ($28.9 billion) was due to increased healthcare and substance abuse treatment costs. Approximately one quarter of the total cost was borne by the public sector through healthcare, substance abuse treatment, and criminal justice costs. The study utilized national data on opioid overdose deaths and abuse/dependence prevalence to estimate costs across multiple sectors including healthcare, substance abuse treatment, criminal justice, and lost productivity.
Vision Session: U.S. Office of Inspector General - From Analytics to Action: A Law Enforcement Perspective on the Use of Data Analytics to Combat Rx Drug Diversion
Survey of likely 2014 likely voters in Arkansas, Colorado, Georgia, Kentucky, Louisiana, Michigan, Montana and North Carolina measuring opinion of the proposed EPA carbon emissions regulations.
10 interesting things about alcohol and other drugs that you might have misse...Andrew Brown
Including - tax revenue from alcohol across Europe, mortality rates for lung cancer, daily doses of OST in Scotland, milligrams of methadone prescribed in Scotland, reasons given for refusing 'place of safety' under the Mental Health Act, calls to the NPIS about drugs, prisoners ability to access drugs and alcohol in England, absconders from prison, re-offending drug offenders in England
Hospital Pricing Issues Cost Employers MoneyMark Gall
This five-year study details the wide variation of hospital prices for the same procedure in the same town. It considers the impact on the costs of private insurance plans from insurance companies including CIGNA, Anthem, Aetna and United HealthCare. See highlights on pages 1 through 6.
This audit report summarizes that while most high-risk offenders in Oregon are assessed for substance abuse problems, only about half receive treatment. The report estimates that if treatment had been provided to all 4,525 highest-risk offenders released from 2008 to 2011, Oregon taxpayers and victims could have avoided approximately $21.6 million in costs related to continued criminal activity. The report recommends that the Department of Corrections work to coordinate funding and track resources to provide substance abuse treatment for more highest-risk offenders where possible.
Drug related deaths in England and Wales reported in 2014Andrew Brown
The Office for National Statistics report that the rates of deaths caused by drug misuse in England and Wales is higher than at any time since comparable records began in 1993
Drivers of drug and alcohol policy in the UKAndrew Brown
This document discusses several issues related to drug and alcohol policy in the UK, including:
1) Trends showing increasing rates of illicit drug use and drug-related deaths, particularly among females.
2) Concerns around new psychoactive substances, the dark net, and organized crime influencing drug supply and misuse.
3) Debates around integrating drug and alcohol treatment services, balancing medication-based treatment with other approaches, and supporting recovery.
4) Calls for potential reforms to drug and alcohol laws and regulation in light of international experiences.
10 interesting things about alcohol and other drugs that you might have misse...Andrew Brown
Including... commissioners plans to reduce spending on services, injecting drug users and HIV, smoking prevalence, proportion of new Europol cases relating to drugs, time people spend on OST, regional variation on emergency hospital admissions for alcohol related liver disease, prisoners use of substances and their relationship to the crimes committed, numbers accessing domestic violence refuges, single homeless people's use of drugs and alcohol
This document provides an overview of state prescription drug monitoring programs (PMPs) and summarizes their status and operations. It finds that 44 states currently operate PMPs that collect prescription data, with most programs housed in health departments or related agencies. States fund PMPs through various means like grants, state appropriations, and licensing/registration fees. Fourteen states receive funding from licensing and registration fees specifically. The overview examines PMP laws and operations to assist policymakers in addressing prescription drug abuse, addiction, and diversion.
This document contains multiple figures and charts related to alcohol and drug use in the UK. It shows that:
1) Between 2013-2014, 584 online drug shops were identified across multiple European countries, with 18% (106 shops) no longer active by May 2014.
2) Data from 26 UK police forces showed that 10% of sexual offenses were alcohol-related.
3) A study found reductions in criminal offending after treatment for alcohol use disorder, with less offending associated with completing treatment and pharmacological therapy.
4) The document presents statistics on drug prices, purity, seizures and other measures related to alcohol and drug use in the UK.
Interesting things about alcohol and other drugs - April 2016Andrew Brown
Scotland's National Naloxone Programme was associated with a 36% reduction in opioid-related deaths after prison release and a 22% reduction after hospital discharge between 2006-2010 and 2011-2013. The number of rough sleepers in England increased 30% from 2014 to 2015, totaling 3,569. In drug-related deaths in Scotland between 2009-2014, 60% of individuals had a known psychiatric condition in the prior 6 months, most commonly depression or anxiety.
Politico Pro Health Care Briefing: Drug Safety and the Trump FDACVS Health
Opening remarks by Thomas M. Moriarty, Executive Vice President, Chief Strategy Officer and General Counsel at the Politico Pro Health Care Briefing: Drug Safety and the Trump FDA, April 5, 2017.
For more on CVS Health's work to ensure access to affordable drugs, visit: http://cvshealth.com/thought-leadership/drug-costs-efficiency-and-the-future-of-the-fda
Florida faces challenges with drug use and consequences, including drug-induced deaths higher than the national average. Marijuana and prescription opioids are primary drugs of abuse treated in Florida. Meth lab seizures rose 148% from 2007-2009. Florida is working to address these issues through initiatives like an authorized but not yet operational prescription drug monitoring program and supporting coalitions through Drug Free Communities grants. In 2010, Florida received over $338 million in federal grants to support reducing drug use.
This report examines CMS's oversight of Medicare Part D beneficiaries who receive opioid prescriptions and providers who prescribe opioids to these beneficiaries. It finds that while CMS provides guidance to Part D plan sponsors on monitoring beneficiaries at high risk of opioid overuse, it lacks complete data on the full population of beneficiaries at risk. It also finds that CMS oversees prescribing through its contractor NBI MEDIC but does not specifically analyze opioid prescription data or require reporting on actions taken regarding inappropriate opioid prescribing. The report concludes that CMS needs more comprehensive oversight to reduce the risks of opioid misuse, overdose, and inappropriate prescribing among Medicare beneficiaries.
The Impact of the AMP Final Rule: Legal, Operational, and Financial Considera...Epstein Becker Green
Part 1 of a webinar series that examines the average manufacturer price (“AMP”) Final Rule and its effect on drug pricing and contracting. Hosted by Epstein Becker Green and EBG Advisors.
The long-awaited issuance of the Final Rule addressing AMP under the Medicaid Drug Rebate Program has provided clarity in some respects but left other issues open to interpretation. In the wake of the Final Rule, other regulatory developments are already showing signs of further impacting many of the same issues.
Using the AMP Final Rule as a baseline, we will address the evolution of some of the most significant issues affecting drug pricing and contracting. We hope you can attend one or both of the sessions in this two-part series.
In this session, Constance A. Wilkinson, Member of the Firm at Epstein Becker Green, will address how the AMP final rule can impact your business. This discussion will examine various legal, operational, and financial factors, including the impact on fee-for-service arrangements with customers, value-based pricing, and reimbursement.
http://www.ebglaw.com/events/the-effect-of-the-average-manufacturer-price-final-rule-on-drug-pricing-and-contracting-part-1-the-impact-of-the-amp-final-rule-legal-operational-and-financial-considerations/
These materials have been provided for informational purposes only and are not intended and should not be construed to constitute legal advice. The content of these materials is copyrighted to Epstein Becker & Green, P.C. ATTORNEY ADVERTISING.
Vermont has many data sources on opioid misuse, abuse and dependence. This data brief covers population prevalence, substance abuse treatment, emergency department visits, and drug-related fatalities involving opioids. There are two main types of opioids that can be misused or abused: prescription opioids (e.g. oxycodone or hydrocodone) and heroin.
A recent report from the Substance Abuse and Mental Health Services Administration found that almost 80% of new heroin users in a given year previously misused prescription pain relievers. The general pattern for Vermont mirrors a national trend: a slow decrease in prescription drug misuse, expanded access to treatment for those dependent on opioids, and an increase in disease and death associated
with heroin use.
Opportunities and Barriers in Pharmaceutical Pricing: Average Manufacturer Pr...Epstein Becker Green
Part 2 of a webinar series that examines the average manufacturer price (“AMP”) Final Rule and its effect on drug pricing and contracting. Hosted by an Epstein Becker Green and EBG Advisors.
The long-awaited issuance of the Final Rule addressing AMP under the Medicaid Drug Rebate Program has provided clarity in some respects but left other issues open to interpretation. In the wake of the Final Rule, other regulatory developments are already showing signs of further impacting many of the same issues.
Using the AMP Final Rule as a baseline, we will address the evolution of some of the most significant issues affecting drug pricing and contracting. We hope you can attend one or both of the sessions in this two-part series.
In this session, Dr. Samuel R. Nussbaum, M.D., Strategic Consultant at EBG Advisors, and Lesley R. Yeung, Associate at Epstein Becker Green, will examine the pay-for-value and alternative approaches to pharmaceutical pricing. The speakers will discuss opportunities and barriers as well as highlight real-world examples.
http://www.ebglaw.com/events/the-effect-of-the-average-manufacturer-price-final-rule-on-drug-pricing-and-contracting-part-2-opportunities-and-barriers-in-pharmaceutical-pricing/
These materials have been provided for informational purposes only and are not intended and should not be construed to constitute legal advice. The content of these materials is copyrighted to Epstein Becker & Green, P.C. ATTORNEY ADVERTISING.
This document analyzes the relationship between substance abuse rates and various economic indicators in the United States from 1992-2012. Regression models were created relating substance abuse treatment data to real GDP, unemployment, and personal income. The results showed that alcohol, crack/cocaine, marijuana, heroin, and amphetamine usage were positively correlated with real GDP, while alcohol was positively correlated with unemployment. Marijuana in particular showed a strong positive relationship with real GDP and personal income. The analysis suggests substance abuse impacts economic indicators in complex ways that vary based on the specific substance.
The economic burden of prescription opioid overdose... 2013.Paul Coelho, MD
The document summarizes a study that estimates the total economic burden of prescription opioid overdose, abuse, and dependence in the United States in 2013 was $78.5 billion. Over one third of this cost ($28.9 billion) was due to increased healthcare and substance abuse treatment costs. Approximately one quarter of the total cost was borne by the public sector through healthcare, substance abuse treatment, and criminal justice costs. The study utilized national data on opioid overdose deaths and abuse/dependence prevalence to estimate costs across multiple sectors including healthcare, substance abuse treatment, criminal justice, and lost productivity.
Vision Session: U.S. Office of Inspector General - From Analytics to Action: A Law Enforcement Perspective on the Use of Data Analytics to Combat Rx Drug Diversion
Survey of likely 2014 likely voters in Arkansas, Colorado, Georgia, Kentucky, Louisiana, Michigan, Montana and North Carolina measuring opinion of the proposed EPA carbon emissions regulations.
10 interesting things about alcohol and other drugs that you might have misse...Andrew Brown
Including - tax revenue from alcohol across Europe, mortality rates for lung cancer, daily doses of OST in Scotland, milligrams of methadone prescribed in Scotland, reasons given for refusing 'place of safety' under the Mental Health Act, calls to the NPIS about drugs, prisoners ability to access drugs and alcohol in England, absconders from prison, re-offending drug offenders in England
Hospital Pricing Issues Cost Employers MoneyMark Gall
This five-year study details the wide variation of hospital prices for the same procedure in the same town. It considers the impact on the costs of private insurance plans from insurance companies including CIGNA, Anthem, Aetna and United HealthCare. See highlights on pages 1 through 6.
This audit report summarizes that while most high-risk offenders in Oregon are assessed for substance abuse problems, only about half receive treatment. The report estimates that if treatment had been provided to all 4,525 highest-risk offenders released from 2008 to 2011, Oregon taxpayers and victims could have avoided approximately $21.6 million in costs related to continued criminal activity. The report recommends that the Department of Corrections work to coordinate funding and track resources to provide substance abuse treatment for more highest-risk offenders where possible.
Drug related deaths in England and Wales reported in 2014Andrew Brown
The Office for National Statistics report that the rates of deaths caused by drug misuse in England and Wales is higher than at any time since comparable records began in 1993
Drivers of drug and alcohol policy in the UKAndrew Brown
This document discusses several issues related to drug and alcohol policy in the UK, including:
1) Trends showing increasing rates of illicit drug use and drug-related deaths, particularly among females.
2) Concerns around new psychoactive substances, the dark net, and organized crime influencing drug supply and misuse.
3) Debates around integrating drug and alcohol treatment services, balancing medication-based treatment with other approaches, and supporting recovery.
4) Calls for potential reforms to drug and alcohol laws and regulation in light of international experiences.
This document discusses the need for increased availability and accessibility of naloxone in England. It notes that legislation is expected to allow wider access to naloxone in October 2015. However, existing provisions should be used now to provide take-home naloxone to those at risk of overdose. Naloxone is a medication that reverses opioid overdoses and can be safely prescribed or issued via various means. Increased access to naloxone training and distribution has the potential to save hundreds of lives by preventing overdose fatalities and brain damage.
DrugScope conducts an annual appraisal of the drug and alcohol treatment sector on behalf of the Recovery Partnership; taking a snapshot of the current conditions for and adaptation of the sector in England.
Drawing on an online survey of managers of adult community and residential services from across the country followed up with in-depth interviews and the views of Chief Executives, State of the Sector provides a detailed insight into the changing nature of drug and alcohol treatment services, the partnerships that are vital to creating recovery outcomes, and challenges for the system.
Drug Related Deaths Summit 2015 - Public Health EnglandAndrew Brown
This document summarizes data on drug-related deaths in England in 2013. The key points are:
- Drug poisoning deaths increased 16% in 2013, driven mainly by a 32% increase in heroin-related deaths. Methadone and codeine deaths also increased.
- Deaths involving other substances like benzodiazepines, cocaine, and amphetamines also rose from 2012 to 2013.
- The increases were seen across age groups and regions of England, and were primarily accidental poisonings among men.
The document discusses rising drug-related deaths in the UK. It notes concerns from the drug and alcohol sector about increasing deaths due to factors like more heroin users leaving services, less outreach work, an aging user population, and higher strength heroin. Some areas reported that increased access to naloxone, which reverses overdoses, prevented deaths. Data showed drug-related deaths rising in some regions from 2013 to 2014. A professional said most deaths were from long-term organ damage in aging opiate users rather than overdoses.
I've been back over the data relating to alcohol in my 'interesting things' series of slide sets and picked out the most interesting ones for this year's Alcohol Awareness Week
Interesting things about alcohol and other drugs - Nov 2016Andrew Brown
One in a regular series of slide sets on interesting data about alcohol and other drugs (and the wider issues to do with multiple needs) from a UK perspective.
Interesting things about alcohol and other drugs that you may have missed - M...Andrew Brown
This month includes data on:
Naloxone, people with drug and alcohol problems getting sickness benefits, numbers sent to treatment through the courts, proportions found guilty of drug offences & the number of previous convictions, re-offence rates for those committing drug offences, rates of death for alcohol, alcohol related violence, drug and drink driving, border force seizures of drugs, how much we spend on 'late intervention', number of times prisons have detected NPS being thrown over the wall, police incidents which include 'legal highs', changes in recorded crime by offence
1) Nearly 1 in 100 people aged 15-64 in Great Britain is considered a high-risk drug user, defined as injecting drugs or regular long-term use of opioids, cocaine, and/or amphetamines.
2) In 2013-14, there were 47,900 child assessments where alcohol or other drugs were a factor, and 435 children in foster care ran away due to substance misuse.
3) Prisoners have high rates of drug use and mental health problems, and older prisoners are more likely to have used Class A drugs before entering custody.
1) Nearly 1 in 100 people aged 15-64 in Great Britain is considered a high-risk drug user, defined as injecting drugs or regular long-term use of opioids, cocaine, and/or amphetamines.
2) In 2013-14, there were 47,900 child assessments where alcohol or other drugs were a factor, and 435 children in foster care ran away due to substance misuse.
3) Prisoners have high rates of drug use and mental health problems, and older prisoners are more likely to have used class A drugs before entering custody.
Problems and challenges faced in consumer reporting of adverse drug reactions...Mohammed Alshakka
This document discusses consumer reporting of adverse drug reactions (ADRs) in developing countries like Yemen, Nepal, and Malaysia. It finds that Malaysia has a good system for consumer involvement, while Yemen lacks drug policies and regulation. Nepal's system is still developing and lacks consumer reporting. Consumer reporting can provide additional information to national pharmacovigilance programs and help reduce ADR-related illness, but is still not widely implemented in developing countries.
This document is the World Drug Report 2013 published by the United Nations Office on Drugs and Crime. It provides a comprehensive overview of the latest developments in global drug markets, including the production, trafficking and use of drugs as well as related health consequences. Chapter 1 examines the global drug situation and trends in different drug markets and the extent of drug use. Chapter 2 addresses the emerging issue of new psychoactive substances, which are not controlled under international drug conventions but may pose health risks. The statistical annex is available electronically on the UNODC website.
This document summarizes drug use trends and issues in New York State. Some key points:
- New York has higher than average rates of cocaine, illicit drug dependence, and young adult illicit drug dependence compared to other states. Heroin is the most common drug in treatment admissions.
- Approximately 9.82% of New York residents reported past-month illicit drug use compared to the national average of 8.82%.
- Drug-induced deaths in New York are lower than the national average, though still number over 1,700 per year.
- The document outlines state and federal efforts to address issues like prescription drug monitoring programs, drug take-back initiatives, and drugged driving laws.
Interesting things about alcohol and other drugs - August 2017Andrew Brown
One in a regular series of slide sets on interesting data about alcohol and other drugs (and the wider issues to do with multiple needs) from a UK perspective.
Interesting things about alcohol and other drugs - March 2017Andrew Brown
One in a regular series of slide sets on interesting data about alcohol and other drugs (and the wider issues to do with multiple needs) from a UK perspective.
Interesting things about alcohol and other drugs - Feb 2017Andrew Brown
One in a regular series of slide sets on interesting data about alcohol and other drugs (and the wider issues to do with multiple needs) from a UK perspective.
STA 544Homework 1Work on the following problem set and show yo.docxsusanschei
STA 544
Homework 1
Work on the following problem set and show your works within the document. Use SPSS as much as possible.
Chapter 1
1. What types of activities other than “calculations” and “math” are associated with the practice of statistics?
2. Define the term measurement.
3. List the three main measurement scales addressed in this chapter.
4. What type of measurement assigns a name to each observation?
5. What type of measurement is based on categories that can be put in rank order?
6. What type of measurement assigns a numerical value that permits for meaningful mathematical operations for each observation?
7. What does GIGO stand for?
8. Provide synonyms for categorical data.
9. Provide synonyms for quantitative data.
10. What is the difference between imprecision and bias
11. How is imprecision quantified?
Chapter 2
1. Controlled-release morphine in patients with chronic cancer pain. Warfield reviewed 10 studies comparing the effectiveness of controlled-release and immediate-release morphine in cancer patients with chronic pain. The studies that were reviewed were double blinded. How would you double blind such studies?
2. What is the general goal of a statistical survey?
3. What is the general goal of a comparative statistical study?
4. What is the key distinction between experimental studies and observational studies?
5. Campus survey. A researcher conducts a survey to learn about the sexual behavior of college students on a particular campus. A list of the undergraduates at the university is used to select participants. The investigator sends out 500 surveys but only 136 are returned.
a. Consider how the low response rate could bias the results of this study.
b. Speculate on potential limitations in the quality of information the researcher will receive on questionnaires that are returned.
6. A study seeks to determine the effect of postmenopausal hormone use on mortality. What is the explanatory variable in this study? What is the response variable?
7. MRFIT. The MRFIT study discussed in an earlier illustrative example studied 12,866 high-risk men between 35 and 57 years of age. Approximately half the study subjects were randomly assigned to a special care group; the other half received their usual source of care. Death from coronary disease was monitored over the next seven or so years. Outline this study’s design in schematic form.
8. Five-City Project. The Stanford Five-City Project is a comprehensive community health education study of five moderately sized Northern California towns. Multiple-risk factor intervention strategies were randomly applied to two of the communities. The other three cities served as controls. Outline the design of this study in schematic form.
By applying factors in combination, experiments can study more than one factor at a time.
paper
by Xx xx
Submission date: 16-Mar-2020 03:51AM (UTC-0400)
Submission ID: 1276359854
File name: internationaldrugtrafficking1.docx (24.71K)
Wo.
Global Medical Cures™ | Responding to America's Prescription Drug Abuse CrisisGlobal Medical Cures™
This document summarizes the growing problem of prescription drug abuse in America. Key points include:
- Prescription drug abuse is now the nation's fastest growing drug problem, with opioids like oxycodone being abused at increasing rates.
- Education of healthcare providers, patients, and the public is needed to increase awareness of the dangers of prescription drug misuse and how to properly use and dispose of medications.
- Tracking programs like prescription drug monitoring programs (PDMPs) in states can help identify "doctor shoppers" and reduce diversion, though more research is still needed on their effectiveness.
- A multifaceted approach including education, monitoring, safe disposal, and enforcement is needed to address the crisis of prescription drug
We honor ourselves when we speak out for recovery. We show the world that recovery matters because it brings hope and peace into the lives of individuals and their loved ones. ~ Beth Wilson
The only person you are destined to become is the person you decide to be. ~ Ralph Waldo Emerson
Success is the sum of small efforts, repeated day in and day out.
~ Robert Collier
Evaluation of NDLEA Radio Campaign Influence on Drug Abuse among Youths in On...inventionjournals
This document evaluates the influence of radio campaigns by the National Drug Law Enforcement Agency (NDLEA) on drug abuse among youths in Onitsha, Nigeria. It uses a survey research method to study youths' awareness of and behavior change from the NDLEA's anti-drug radio programs. The study finds it difficult to get youths to openly discuss drug use due to fears of arrest. As a result, it relies on youth opinions obtained through private surveys rather than interviews. The study aims to determine the level of awareness and influence the radio campaigns have had in reducing drug abuse among Onitsha youths.
10 interesting things about alcohol and other drugs that you may have missed ...Andrew Brown
Including a call for the NHS and social services to address stigma issues, some of the key statistics from the Chief Medical Officer for England's report, European data on drugs and people who go to prison, drink driving offences in Great Britain, a comparison between drink driving and drug driving in those who use substances, football and alcohol offences, Lithuania as a source of methamphetamine in the UK, and the recovery rate of those using IAPT services who are diagnosed with alcohol problems.
The Opioid Crisis: The Important Role of CPAsPYA, P.C.
The document summarizes a presentation on the opioid crisis and the role of CPAs. It provides an overview of the scope and history of the crisis, describes recent case examples of fraud and abuse, and outlines affected industries and risk areas that require internal controls monitoring. It also discusses what CPAs can do to help address the crisis, such as focusing on the flow of money, monitoring drug costs, investigating physician payments from pharmaceutical companies, and ensuring compliance to avoid litigation.
ER visits for opioid overdoses is rising in the U.S. Accurate ER reports from medical transcription services and proactive action can help minimize risks.
The Opioid Epidemic: An Important Auditor UpdatePYA, P.C.
PYA Tampa Office Managing Principal Angie Caldwell and Consulting Senior Manager Sarah Bowman addressed “The Opioid Epidemic: An Important Auditor Update” in their presentation. They:
Provided an overview of the scope of the opioid crisis, emerging trends in opioid abuse, and recent regulatory activity.
Analyzed key internal control risk areas to prevent drug diversion.
Reviewed specific examples of monitoring for fraud and abuse related to the opioid epidemic.
This document provides a summary of a policy audit report on fertility that analyzed policies in 9 EU countries. It finds that over 25 million EU citizens are affected by infertility, though rates of infertility are difficult to compare across countries due to different data methodologies. Fertility rates in the 9 countries range from 1.32 in Spain and Poland to 2.01 in France. The report includes country profiles of fertility policies, diagnosis and treatment availability, funding, and awareness efforts in each of the Czech Republic, France, Germany, Italy, Poland, Romania, Spain, Sweden, and the UK.
Interesting things about alcohol and other drugs - November 2017Andrew Brown
This document contains multiple summaries and statistics related to alcohol and drug use in the UK:
- The number of adults in community drug and alcohol treatment has fallen slightly in recent years, particularly for alcohol alone. Crack cocaine problems have increased 23%.
- Housing problems fell for most substance users between starting treatment and 6 months later, ranging from 3-5% reductions.
- Non-fatal overdoses have risen among people who inject drugs in England, reaching 19% in 2016. Rates are lower for those currently in treatment.
- Reoffending fell 33% overall for those in community substance misuse treatment, with the greatest reductions for alcohol-only clients in both offenders (59%) and offenses
Interesting things about alcohol and other drugs - October 2017Andrew Brown
One in a regular series of slide sets on interesting data about alcohol and other drugs (and the wider issues to do with multiple needs) from a UK perspective.
Interesting things about alcohol and other drugs - July 2017Andrew Brown
One in a regular series of slide sets on interesting data about alcohol and other drugs (and the wider issues to do with multiple needs) from a UK perspective.
Interesting things about alcohol and other drugs - June 2017Andrew Brown
One in a regular series of slide sets on interesting data about alcohol and other drugs (and the wider issues to do with multiple needs) from a UK perspective.
Interesting things about alcohol and other drugs - May 2017Andrew Brown
One in a regular series of slide sets on interesting data about alcohol and other drugs (and the wider issues to do with multiple needs) from a UK perspective.
Interesting things about alcohol and other drugs - April 2017Andrew Brown
One in a regular series of slide sets on interesting data about alcohol and other drugs (and the wider issues to do with multiple needs) from a UK perspective.
Interesting things about alcohol and other drugs - Dec 2016Andrew Brown
One in a regular series of slide sets on interesting data about alcohol and other drugs (and the wider issues to do with multiple needs) from a UK perspective.
Interesting things about alcohol and other drugs - Oct 2016Andrew Brown
One in a regular series of slide sets on interesting data about alcohol and other drugs (and the wider issues to do with multiple needs) from a UK perspective.
Interesting things about alcohol and other drugs - July 2016Andrew Brown
The document contains information from various sources about drugs, alcohol, and related harms. It includes statistics on deaths in custody, drug and alcohol prices in different regions, alcohol sales data showing cheap prices, drug use in prisons has increased significantly with almost daily use, childhood abuse is linked to various mental health and substance use issues later in life, injecting equipment provision outlets in Scotland have seen a large rise in attendances, approximately one in six people with drug dependence receive treatment globally, alcohol-related deaths are much higher in males than females and increase with age.
Interesting things about alcohol and other drugs - Feb 2016Andrew Brown
The document provides statistics and information about alcohol and drug use and related harms in the UK:
- The number of individuals disqualified from driving due to drink or drug driving offenses has increased each year from 2011 to 2015.
- Prisoners are much more likely than the general population to have experienced adverse childhood experiences like abuse, violence at home, and time in care, and to have issues like unemployment, homelessness, and mental health problems.
- Alcohol-related deaths have been decreasing in the UK overall since the early 2000s, though rates are still higher in northern regions of England and Scotland compared to southern regions.
12 things we learnt about drug and alcohol treatment in Wales in 2014-15Andrew Brown
The document summarizes key statistics from the Welsh National Database for Substance Misuse about drug and alcohol treatment in Wales in 2014-2015. Some of the main findings include: referrals were highest among those aged 25-34 for both males and females; the most common sources of referrals were GPs, self-referrals, and criminal justice; cannabis and alcohol were the most common problematic substances; the number of people in treatment increased slightly from 2013-2014; and the most common treatment types delivered were psychosocial interventions, brief interventions, and harm reduction.
6 things for the Education Select Committee to think aboutAndrew Brown
The Education Select Committee of the UK House of Commons are undertaking an inquiry into the mental health and wellbeing of children in the looked after system. Here are 6 things they should know...
RFP for Reno's Community Assistance CenterThis Is Reno
Property appraisals completed in May for downtown Reno’s Community Assistance and Triage Centers (CAC) reveal that repairing the buildings to bring them back into service would cost an estimated $10.1 million—nearly four times the amount previously reported by city staff.
Food safety, prepare for the unexpected - So what can be done in order to be ready to address food safety, food Consumers, food producers and manufacturers, food transporters, food businesses, food retailers can ...
Preliminary findings _OECD field visits to ten regions in the TSI EU mining r...OECDregions
Preliminary findings from OECD field visits for the project: Enhancing EU Mining Regional Ecosystems to Support the Green Transition and Secure Mineral Raw Materials Supply.
AHMR is an interdisciplinary peer-reviewed online journal created to encourage and facilitate the study of all aspects (socio-economic, political, legislative and developmental) of Human Mobility in Africa. Through the publication of original research, policy discussions and evidence research papers AHMR provides a comprehensive forum devoted exclusively to the analysis of contemporaneous trends, migration patterns and some of the most important migration-related issues.
Working with data is a challenge for many organizations. Nonprofits in particular may need to collect and analyze sensitive, incomplete, and/or biased historical data about people. In this talk, Dr. Cori Faklaris of UNC Charlotte provides an overview of current AI capabilities and weaknesses to consider when integrating current AI technologies into the data workflow. The talk is organized around three takeaways: (1) For better or sometimes worse, AI provides you with “infinite interns.” (2) Give people permission & guardrails to learn what works with these “interns” and what doesn’t. (3) Create a roadmap for adding in more AI to assist nonprofit work, along with strategies for bias mitigation.
This report explores the significance of border towns and spaces for strengthening responses to young people on the move. In particular it explores the linkages of young people to local service centres with the aim of further developing service, protection, and support strategies for migrant children in border areas across the region. The report is based on a small-scale fieldwork study in the border towns of Chipata and Katete in Zambia conducted in July 2023. Border towns and spaces provide a rich source of information about issues related to the informal or irregular movement of young people across borders, including smuggling and trafficking. They can help build a picture of the nature and scope of the type of movement young migrants undertake and also the forms of protection available to them. Border towns and spaces also provide a lens through which we can better understand the vulnerabilities of young people on the move and, critically, the strategies they use to navigate challenges and access support.
The findings in this report highlight some of the key factors shaping the experiences and vulnerabilities of young people on the move – particularly their proximity to border spaces and how this affects the risks that they face. The report describes strategies that young people on the move employ to remain below the radar of visibility to state and non-state actors due to fear of arrest, detention, and deportation while also trying to keep themselves safe and access support in border towns. These strategies of (in)visibility provide a way to protect themselves yet at the same time also heighten some of the risks young people face as their vulnerabilities are not always recognised by those who could offer support.
In this report we show that the realities and challenges of life and migration in this region and in Zambia need to be better understood for support to be strengthened and tuned to meet the specific needs of young people on the move. This includes understanding the role of state and non-state stakeholders, the impact of laws and policies and, critically, the experiences of the young people themselves. We provide recommendations for immediate action, recommendations for programming to support young people on the move in the two towns that would reduce risk for young people in this area, and recommendations for longer term policy advocacy.
2. Number of current drug injectors admitted to first drug
treatment, by country
“A total of 12,909 current drug
injectors were admitted to first drug
treatment in 2011, with the United
Kingdom (34.8 %) accounting for the
largest proportion of reported cases,
followed by the Czech Republic (16.6
%), Italy (13.7 %), Greece (6.6 %),
Spain (5.7 %) and Germany (5.0 %).”
Source: http://www.emcdda.europa.eu/publications/technical-reports/trends-in-injecting-drug-use
3. Age of first use
Source:
http://www.emcdda.europa.eu/data/stats2015#di
splayTable:TDI-0197
4. Employment status of people with poor health status
“there seems to be a
substantial labour market
disadvantage for those
reporting that they have poor
alcohol/drug status. Those
with poor alcohol/drug status
have a 50 per cent lower
employment incidence and a
five-fold greater probability of
being unemployed (21 per
cent vs. 4.6 per cent).”
Source: http://www.jrf.org.uk/publications/does-poor-health-affect-employment-
transitions?
5. Incidence of positive tests for blood borne viruses by
setting
Source:
https://www.gov.uk/government/uploads/
system/uploads/attachment_data/file/434
951/HJ_report_11_6.pdf
6. What makes people with a severe mental illness more
likely to be a victim of crime?
“We assessed nearly 30
demographic, socio-economic,
social, developmental,
behavioural and clinical
factors that could be related to
risk of victimisation among
people with SMI, but only
three were independently
correlated with this outcome:
service engagement, drug
misuse and a history of being
violent.”
Victim Support
Source: https://www.victimsupport.org.uk/sites/default/files/At%20risk%20full.pdf
7. When do people with substance use problems turn up
at hospital in acute need?
“We found that access to, and the quality of,
services after 5pm was not good enough.
Commissioners and providers should make
sure that they have the most appropriate
services with the staff that have the right
skills working at the times when people with
mental health needs are more likely to
access them.”
CQC - “Right here, right now – help, care
and support during a mental health crisis”
Source:
http://www.cqc.org.uk/sites/default/files/20150611_righthere_mhcrisiscare_full_3b.pdf
8. How substance use disorders contribute to mental
health related crises being seen at A&E
Source:
http://www.cqc.org.uk/sites/default/files/201506
11_righthere_mhcrisiscare_full.pdf
9. Heroin in the UK
For every tonne of heroin
that the National Crime
Agency and other
enforcement agencies seize
between 4 and 5 tonnes are
imported into the UK.
Tonnes of heroin
seized in the first
year of the NCA’s
existence.
Estimated tonnes of
heroin imported
annually into the UK.
Source: http://www.nationalcrimeagency.gov.uk/crime-threats/drugs
10. How might changing the law on drug possession and
sale affect use
“Only a minority of GDS [Global Drug Survey]
respondents (a group who are already interested in drug
use) stated that they would increase their use. Our
analysis suggests that these stated intentions are
influenced by the leniency of the policy scenarios. Stated
intentions to increase use tended to increase as the
policy scenario became more lenient…
“It is also intriguing that many GDS respondents
reported intentions to reduce alcohol use in response to
more liberal drug policy scenarios. This suggests that
any increases in harm from increased drug use might,
according to these stated intentions, be offset by
reductions in harms from alcohol use.”
Source: http://bit.ly/1Sog9tj
11. Impact of Operation Pangea VIII (9-16 June 2015)in the
UK
doses of falsified,
counterfeit and
unlicensed medicines
seized*
6.2m
15.8 m
£
worth a total of
*almosttwiceas
muchaslastyear
The UK operation also
resulted in 1,380 websites
being closed down
339 of which were domestic
sites.Source: http://bit.ly/opPangea
12. UK public service delivery using PbR
“If PbR can deliver the benefits its
supporters claim – such as innovative
solutions to intractable problems – then
the increased cost and risk may be
justified, but this requires credible
evidence. Without such evidence,
commissioners may be using PbR in
circumstances to which it is ill-suited,
with a consequent negative impact on
value for money.”
National Audit Office
“In the first year of the pilot ‘Payment by Results for Drugs Recovery’
scheme in England, linking payments to outcomes reduced the
probability of completing drug misuse treatment and increased the
proportion service users declining to continue with treatment.”
Mason et al. (2015) The impact of paying treatment providers for outcomes:
difference-in-differences analysis of the ‘payment by results for drugs recovery’
pilot.
Sources:
http://www.nao.org.uk/report/outcome-based-payment-schemes-governments-use-
of-payment-by-results/
http://onlinelibrary.wiley.com/doi/10.1111/add.12920/abstract
13. How good is your area at working with dual diagnosis?
The Hard Edges report suggested
that three in every five people
in treatment for substance use
problems is also suffering
from a diagnosed mental
health problem.
PHE’s fingertips tool suggests
that on average across England
about one in five people in
treatment are having
concurrent contact with
mental health services.
Source: http://fingertips.phe.org.uk/profile-group/mental-health/profile/drugsandmentalhealth
14. Why are people admitted to hospital when the cause is
alcohol related
In 2013/14, there were
an estimated
1,059,210 admissions
related to alcohol
consumption where an
alcohol-related
disease, injury or
condition was the
primary reason for
hospital admission or
a secondary diagnosis.
15. How the alcohol market changed last year
Source: http://www.thedrinksreport.com/news/2015/16101-uk-alcohol-market-returns-to-
growth.html
“The WSTA’s Q2 2015 Market
Report shows that the UK
alcohol market has returned to
growth following years of
continuous decline. The report
shows modest growth in off
trade volumes and a slowing of
the decline in the on trade,
resulting in overall volume
growth for the first time in five
years.”